Dr. Gregory Taroyan, MD

Dr. Taroyan practices at Freestone Medical Center in Fairfield, Texas, part of Freestone Medical Center.

Dr. Taroyan's NPI, 1114337540, was assigned on May 7, 2014. Dr. Taroyan graduated from UTMB Health in 2014. Dr. Taroyan holds Texas license R3440.

Dr. Taroyan's primary practice is Freestone Medical Center, at 125 Newman St, Fairfield, TX 75840 in Freestone County. The practice phone is (903) 389-1612.

Dr. Taroyan's primary practice is Freestone Medical Center in Fairfield, Texas, part of Freestone Medical Center. Dr. Taroyan is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Concord Medical Group. Dmand AI also links Dr. Taroyan to 4 more hospitals and 7 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taroyan practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Taroyan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Taroyan is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Taroyan is licensed in Texas.

CMS data shows 109 Medicare services from Dr. Taroyan across 4 procedure codes in 2024, for 101 Medicare patients. Medicare paid $8,821 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Taroyan in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taroyan's median patient age at 44, with 56% women.

In 2024, Dr. Taroyan wrote 197 Medicare Part D claims for 108 patients. 97% of them were for generic drugs. CMS names the drug for 89 of them, across 4 drugs with 11 or more claims each, at $780 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Taroyan for performance year 2024, reported as part of a group. Dr. Taroyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Taroyan in 2018. Dr. Taroyan's most frequent co-author is Andrew Louis Juergens, MD.

Dr. Taroyan graduated from UTMB Health in 2014.

Dr. Taroyan is in network with 21 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.